Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
Ipamorelin
Ipamorelin Description
Ipamorelin is a synthetic peptide studied extensively as a growth hormone secretagogue in laboratory research. This compound belongs to the growth hormone-releasing peptide (GHRP) class and serves as a research tool for examining pituitary receptor interactions and growth hormone release mechanisms.
Ipamorelin is a pentapeptide (composed of 5 amino acids) that functions as a ghrelin mimetic in experimental models. Developed in the 1990s for research applications, this compound demonstrates selective growth hormone release properties without affecting other pituitary hormones, distinguishing it from earlier-generation peptides in laboratory studies.
The compound shows high specificity for the GHS-R1a receptor, enabling targeted investigation of physiological responses in vitro. Its selective mechanism has established it as a valuable research tool for investigating growth hormone signaling pathways, metabolic regulation, and receptor-ligand interactions in scientific studies.
Peptide Information
| Property | Value |
|---|---|
| Peptide Sequence | Aib-His-D-2Nal-D-Phe-Lys |
| Molecular Formula | C38H49N9O5 |
| Molecular Weight | 711.9 g/mol |
| CAS Number | 170851-70-4 |
| PubChem CID | 9831659 |
| Synonyms | 170851-70-4, Ipamorelin [INN], NNC-26-0161, UNII-Y9M3S784Z6 |
Ipamorelin Research
What is the research background of Ipamorelin?
Delayed gastric emptying is a common condition, and currently, there are few effective treatment options. Research has found that Ipamorelin, as a synthetic peptidomimetic, acts on the ghrelin receptor and may have a therapeutic effect on delayed gastric emptying. In a study on a rodent model of gastroparesis, gastroparesis was induced by abdominal surgery and intestinal manipulation, and it was found that Ipamorelin could accelerate gastric emptying[1].
Postoperative ileus is a significant challenge in clinical practice, lacking effective management strategies. Ghrelin receptor stimulation has a motility-promoting effect on both the upper and lower parts of the gastrointestinal tract. As a ghrelin receptor agonist, Ipamorelin has potential application value in the treatment of postoperative ileus. For example, in a study, a prospective, randomized, controlled proof-of-concept study was conducted on patients undergoing intestinal resection after abdominal surgery to evaluate the safety and effectiveness of Ipamorelin[2].
Ipamorelin belongs to the growth hormone releasing peptides (GHRPs), which is a synthetic pentapeptide capable of stimulating the release of growth hormone from the hypothalamus and pituitary gland. Growth hormone plays an important role in the body's growth, repair, and metabolism, so the role of Ipamorelin in regulating growth hormone has also attracted widespread attention[3].
Due to its potential value in treating delayed gastric emptying, postoperative ileus, and its role as a growth hormone releasing peptide, Ipamorelin has attracted extensive research attention.
What is the mechanism of action of Ipamorelin?
1. Stimulating the release of growth hormone:
Ipamorelin belongs to the growth hormone releasing peptides (GHRPs), which can stimulate the release of growth hormone from the hypothalamus and pituitary gland. In vitro and in vivo experiments, Ipamorelin has shown high potency and efficacy in releasing growth hormone. For example, in a study, the potency and efficacy of Ipamorelin in releasing growth hormone from primary rat pituitary cells were similar to those of GHRP-6[3]. Its mechanism of action is to stimulate the release of growth hormone by activating GHRP-like receptors. Through pharmacological analysis, it has been confirmed that like GHRP-6, Ipamorelin stimulates the release of growth hormone through GHRP-like receptors.
2. Effects on the gastrointestinal tract
Accelerating gastric emptying:
In rodent models, Ipamorelin can accelerate gastric emptying. Abdominal surgery leads to delayed gastric emptying, but after administration of Ipamorelin (0.014 µmol/kg intravenously), gastric emptying is significantly accelerated. Ipamorelin stimulates gastric contractility and accelerates gastric emptying through a mechanism mediated by the activation of the ghrelin receptor, involving cholinergic excitatory neurons (Greenwood-Van Meerveld B, 2012).
Improving symptoms of postoperative ileus:
In rodent models of postoperative ileus, Ipamorelin may improve the symptoms. After postoperative administration of Ipamorelin, a single dose of Ipamorelin (1mg/kg) or GHRP-6 (20μg/kg) can reduce the time to first defecation. Repeated administration of Ipamorelin (0.1 or 1mg/kg) can significantly increase the cumulative fecal output, food intake, and weight gain [4].
3. Effects on insulin secretion
Ipamorelin can stimulate insulin secretion in pancreatic tissue fragments of normal and diabetic rats. The increase in insulin secretion induced by Ipamorelin can be significantly inhibited by diltiazem, yohimbine, propranolol, or a combination of atropine, propranolol, and yohimbine. In diabetic rats, atropine can significantly reduce the insulin secretion induced by Ipamorelin, but this effect is not observed in normal rats. This indicates that Ipamorelin stimulates insulin release through the calcium channel and adrenergic receptor pathways[5].
4. Alleviating pain
In experimental models of non-inflammatory visceral hypersensitivity and somatic mechanical allodynia, Ipamorelin, as a peripherally restricted ghrelin receptor agonist, can significantly reduce colonic hypersensitivity and somatic allodynia. Its mechanism of action is mediated by the ghrelin receptor, and this antinociceptive effect can be blocked by the ghrelin receptor antagonist H0900[6].
Shows the effect of ipamorelin on insulin secretion from pancreatic tissue fragments of normal and diabetic rats.
Source:PubMed[5]
What are the applications of Ipamorelin?
1. Promoting the release of growth hormone
Ipamorelin can stimulate the release of growth hormone from the hypothalamus and pituitary gland. Growth hormone plays an important role in the human body, including promoting protein synthesis, cell proliferation, and tissue repair. Therefore, Ipamorelin can be used to treat growth hormone deficiency or other diseases related to growth hormone insufficiency[7].
2. Improving gastrointestinal function
Accelerating gastric emptying:
In rodent models, Ipamorelin accelerates gastric emptying in models of postoperative ileus through a mechanism mediated by the activation of the growth hormone releasing peptide receptor, involving cholinergic excitatory neurons[1]. Abdominal surgery leads to delayed gastric emptying, and administration of Ipamorelin can significantly reduce the proportion of residual food in the stomach, thereby improving gastric motility.
Promoting gastrointestinal peristalsis:
In rodent models of postoperative ileus, Ipamorelin may improve the symptoms of patients. For example, in a rat model, Ipamorelin can reduce the time to first defecation after surgery, increase fecal output, food intake, and weight gain[4]. Repeated administration of Ipamorelin can significantly increase the cumulative fecal output, food intake, and weight gain, indicating its positive regulatory effect on gastrointestinal function.
3. Relieving pain
Relieving visceral and somatic pain:
Research shows that Ipamorelin, as a growth hormone releasing peptide receptor agonist, has antinociceptive properties. In experimental models without colonic epithelial inflammation, Ipamorelin can significantly reduce non-inflammatory visceral hypersensitivity and somatic mechanical allodynia[6].
Its mechanism of action may be mediated by the growth hormone releasing peptide receptor, participating in the regulation of visceral and somatic hypersensitivity, providing a potential new method for the treatment of acute visceral and somatic pain.
What are the research progress of Ipamorelin in the treatment of growth hormone deficiency?
Growth hormone deficiency is a disease caused by insufficient secretion of growth hormone from the anterior pituitary gland, which can affect the growth and development of children and the body metabolism of adults. In recent years, Ipamorelin, as a growth hormone secretagogue, has attracted widespread attention in the treatment of growth hormone deficiency. The following is the relevant research progress of Ipamorelin in the treatment of growth hormone deficiency.
1. The stimulating effect of Ipamorelin on growth hormone secretion
Ipamorelin can stimulate the secretion of growth hormone. Research shows that Ipamorelin can act synergistically with growth hormone releasing hormone (GHRH) to enhance the release of growth hormone[8]. In animal experiments, after 21 days of chronic treatment with Ipamorelin in young female rats, compared with the control group, the basal growth hormone release in the monolayer culture of pituitary cells increased. At the same time, Ipamorelin and GHRH can stimulate the release of growth hormone from cultured pituitary cells in vitro. However, in the GHRH pretreatment group, the subsequent growth hormone response to stimulation was not enhanced, while in the Ipamorelin pretreatment group, there was no such desensitization phenomenon, indicating that Ipamorelin does not lead to desensitization of the growth hormone response in young female rats[8].
2. The effect of Ipamorelin on weight gain
Chronic administration of Ipamorelin can effectively increase the weight of young female rats. Daily monitoring shows that the percentage of weight gain in the Ipamorelin pretreatment group and the GHRH pretreatment group is higher than that in the control group[8]. This is related to the fact that Ipamorelin stimulates the secretion of growth hormone, which in turn promotes protein synthesis and cell growth.
3. The effect of Ipamorelin on bone formation
In an adult rat model, it has been found that the growth hormone secretagogue Ipamorelin can counteract the catabolic effects of glucocorticoids (GC) on skeletal muscle and bone. Compared with the group injected with GC alone, in the animals injected with both GC and Ipamorelin, the maximum tetanic tension of the calf muscle increased significantly, and the periosteal bone formation rate increased fourfold [8, 9]. This indicates that Ipamorelin has a positive effect on maintaining muscle strength and promoting bone formation, and may help prevent complications such as osteoporosis in patients with growth hormone deficiency.
4. The effect of Ipamorelin on gastrointestinal function
As a selective growth hormone-releasing hormone agonist and growth hormone-releasing peptide receptor agonist, Ipamorelin demonstrated therapeutic efficacy in a mouse model of postoperative intestinal paralysis. Single administration of Ipamorelin or growth hormone-releasing peptide (GHRP)-6 shortened the time to the first postoperative bowel movement, but had no effect on cumulative fecal output, food intake, or weight gain. Ipamorelin increases cumulative fecal output, food intake, and weight gain. This suggests that Ipamorelin may have a certain role in improving gastrointestinal function and may help improve digestive and absorptive function in patients with growth hormone deficiency.[4].
In summary, as a selective growth hormone secretion promoter, Ipamorelin efficiently stimulates the release of growth hormone by activating the growth hormone-releasing peptide receptor (GHS receptor), without significantly affecting the levels of adrenocorticotropic hormone (ACTH) and cortisol. Its functions include promoting growth hormone secretion, regulating gastrointestinal motility, and alleviating pain. Its high selectivity and multi-target characteristics confer clinical application potential, making it suitable for use in conditions such as growth hormone deficiency, postoperative intestinal obstruction, and pain management.
For Research Use Only
This compound is provided exclusively for in vitro laboratory research. It is not intended for human or animal consumption, diagnosis, treatment, or medical use. Not for dietary, cosmetic, or veterinary purposes. This product has not been evaluated by the U.S. Food and Drug Administration or any other regulatory authority.
Disclaimer
All information is for educational purposes only. Humatide makes no claims regarding efficacy or safety. Purchasers are responsible for ensuring proper handling and use in compliance with all applicable laws and regulations.
Terms of Sale
By purchasing from Humatide, you confirm that you are a qualified researcher with the knowledge and facilities to safely handle and store research chemicals. All sales are final. Humatide assumes no liability for misuse, misrepresentation, or unintended consequences arising from the use of this product.
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.
The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.
Polypeptide Purity Control and Verification Technical System
Humatide.com provides peptides with purity exceeding 99%. Humatide achieves precise control and scientific verification of polypeptide purity by integrating advanced technologies and a full-process quality control system: In the synthesis stage, automated solid-phase peptide synthesis (SPPS) is employed to accurately assemble amino acid sequences. A gradient purification strategy ranging from medium-pressure liquid chromatography (MPLC) to preparative high-performance liquid chromatography (Prep-HPLC) is utilized, optimizing mobile phase composition and elution conditions based on the physicochemical properties of the target peptide (hydrophobicity, charge distribution, etc.) to efficiently remove impurities. For purity detection, reverse-phase high-performance liquid chromatography (RP-HPLC) serves as the core technique, separating components through the distribution difference of molecules between the stationary phase (hydrophobic packing) and the mobile phase (polar solvent). Purity is determined via retention time matching and peak area normalization. Meanwhile, electrospray ionization mass spectrometry (ESI-MS) is combined to precisely verify the molecular weight and composition through mass-to-charge ratio (m/z) analysis, eliminating structurally heterogeneous impurities. Quality management covers the entire chain from raw material acceptance, synthesis process monitoring to finished product release. A continuous quality fingerprint is constructed using multi-dimensional indicators (HPLC purity, MS molecular weight, solvent residue, etc.), and batch data traceability is achieved through a laboratory information management system (LIMS), ensuring each batch meets the prespecified purity standards. This system provides a reliable technical guarantee for preparing high-purity polypeptides through the organic integration of process optimization, multi-dimensional detection, and full-process quality control.
Concepts of High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS)
High-performance liquid chromatography (HPLC) is a separation technology widely used by Humatide for peptide purification. Driven by a high-pressure pump, the mobile phase carries samples through a chromatographic column packed with a specific stationary phase, achieving separation based on differences in the distribution coefficients of components between the two phases. It features high separation efficiency, fast analysis speed, and strong detection sensitivity, enabling precise capture of subtle differences between target peptides and impurities such as sequence analogs or deletion peptides.
Mass spectrometry (MS) is an analytical method that converts peptide molecules into gas-phase ions through ionization technology and separates/detects ions based on their mass-to-charge ratio (m/z). It can accurately determine the molecular weight of peptides and infer amino acid sequences through fragment ion information, serving as a key technology for verifying peptide structural correctness. The combination of these two techniques allows Humatide to establish a complete quality control system from both purity separation and structural confirmation perspectives. Both methods are high-precision peptide detection technologies that scientifically demonstrate the purity and composition of peptides ordered from Humatide.com.
Humatide is committed to translating cutting-edge analytical technologies into tangible quality assurance. Our peptide synthesis laboratories are equipped with high-resolution mass spectrometers and ultra-high-performance liquid chromatography systems. Through real-time detection and data comparison of samples at each production stage, we continuously optimize synthesis processes to ensure every peptide product is delivered to customers with exceptional purity.
Recommended Peptide Purity Levels
Humatide provides only the highest-purity peptides (purity ≥99%) for research and development. The minimum recommended peptide purity level for specific applications depends on the application:
• In biochemical research, peptides used for enzyme activity analysis typically require ≥85% purity.
• In drug development, peptides for preclinical trials must meet >98% high-purity standards to ensure biological activity and safety.
• For diagnostic applications (e.g., antigen peptides in immunoassays), recommended purity is 90%-95% to guarantee detection specificity and sensitivity.
Humatide is confident in the quality of all our products, implementing strict quality monitoring at every stage of peptide synthesis—from crude peptide purification to final product release. Through multi-step purification and verification processes, we ensure each batch meets or exceeds the purity requirements for specific applications. Examples of acceptable minimum purity levels are as follows:
High Purity (>95%)
• Polypeptide drug research and production
• Preparation of targeted therapeutic drugs
• Raw materials for biological diagnostic reagents (e.g., ELISA, immunoassay kits)
• Development of polypeptide vaccines (therapeutic/preventive)
• Preparation of targeting peptides for antibody-drug conjugates (ADCs)
• Polypeptide reagents for life science research (e.g., receptor agonists/antagonists)
• Research on targeting peptide modification for gene therapy vectors
• Development of polypeptide antibiotics/antimicrobial peptides
• Preparation of polypeptide hormone analogs (e.g., insulin analogs)
• Reference standards for biomarker detection
• Research on cell culture additives
• Synthetic peptides for protein structure analysis and functional studies
Moderate Purity (>85%)
• Early-stage activity screening in polypeptide drug research
• Peptide additives for industrial enzymes
• Signal peptide raw materials
• Surface modification of biomaterials (e.g., medical catheters, tissue engineering scaffolds)
• Preparation of agricultural antimicrobial peptides
• Cell adhesion research
• Raw materials for polypeptide surfactants/detergents
• Polypeptide reagents for preliminary mechanistic research in scientific studies
Lower Purity (>70%)
• Preliminary structure-activity relationship (SAR) studies
• Initial verification of protein binding
• Primary cytotoxicity screening
• High-throughput screening of polypeptide drug lead compounds
Please note
**We are not responsible for reconstitution or any issue that arise from it**
High-purity polypeptides are suitable for scenarios requiring strict purity. The ultra-high-purity peptides provided by Humatide can meet and exceed all prespecified purity standards.
Humatide Shipping & Delivery
Shipping Methods & Delivery Times
Standard handling is 24 hours excluding Holidays and Weekends
International Shipping – Not available at this time.
The explained transit time are not guaranteed. Humatide is not responsible nor will refunds be given due to transit delays.
Order Tracking
Once your order has shipped, you’ll receive an email with a tracking number and link.
If you experience any tracking issues, reach out to us at help@humatide.com.
Shipping Issues
If your order arrives damaged, incorrect, or incomplete, contact us within 48 hours of delivery at help@humatide.com. Please have photos available to expedite inquires. We’ll make it right with a replacement or refund.
Carrier Delays
Humatide is not responsible for delivery delays caused by:
- Severe weather
- Carrier errors
- Events outside our control
- Extended transit times in rural areas
- Holidays
Address Accuracy
Please double-check your shipping address during checkout.
We are not responsible for orders delayed or lost due to incomplete or incorrect addresses.
Delivery Confirmation
If tracking shows your package as delivered but you haven’t received it:
Contact UPS directly.
We’re happy to assist with a carrier claim, but Humatide is not liable for lost or stolen packages after confirmed delivery.
Returns & Exchanges
Refund Policy
Due to the sensitive nature of research products, all sales are final.
We cannot accept returns or issue refunds once an order has been shipped. This policy helps ensure product integrity and safety for all of our research partners.
Damaged or Defective Items
If your order is damaged and you declined shipping protection we can only provide you with up to $100 in store credit. If you did select shipment protection we will replace any damaged good and ship out replacements at no cost. If your order is incorrect, or missing items, please contact us within 48 hours of delivery so we can resolve the issue. Please provide photos of the damaged items.
Lost or Stolen Shipments
If your order is lost or stolen and you declined shipping protection the maximum credit we can give you is $100 in store credit. If you did select shipment protection we will replace the entire order if it's been lost at no charge if it is lost or stolen. Please contact us within 48 hours of delivery so we can work with UPS to help resolve the issue.
Final Sale Items
All sales are final and products are not eligible for return or exchange.
Need Help?
We’re here to help.
Contact our support team anytime at help@humatide.com with any questions about shipping or returns.
To View the latest Certificate of Analysis (CoA) click the "View Latest 3rd Party Certificate of Analysis" button on the product page. Please use that if you are looking to buy as that is the batch you'll receive if you place an order. The QRCode will give you the Batch ID/Lot Number which is matched on the CoA to validate that CoA matches your specific vial. If you happen to get a vial that is from a previous batch select the "Previous Batch 3rd Party Certificate of Analysis" if your Batch ID doesn't match the latest CoA.
All CoA are searchable via the respective testers' website.
ILS Labs Verification is available on their website at:
To validate the CoA on the ILS Labs website enter the Access Code that is located on the bottom of the CoA that is shown on our website.
We also use MDx Biolabs, verification is available via their website at:
https://mdxbiolabs.com/certificates-of-analysis
To find validate the CoA on the MDx Biolabs website enter the COA number which is located at the bottom of the CoA that is shown on our website.
Ipamorelin
10MG
$35
